ELFN1 and colorectal carcinoma: To adequately evaluate the biological function of ELFN1-AS1 in CRC, we manipulated the levels of ELFN1-AS1 and discovered that overexpressing ELFN1-AS1 alone was able to enhance cell viability, maintain cell survival, and impair sensitivity of CRC cells to oxaliplatin (Fig. 7c, d, Supplementary Fig. S7d–i).